Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214569 | SCV000270355 | likely benign | not specified | 2015-03-30 | criteria provided, single submitter | clinical testing | c.897-14T>C in intron 6 of LDB3: This variant is not expected to have clinical s ignificance because a T>C change at this position does not diverge from the spli ce consensus sequence and is therefore unlikely to impact splicing. It has also been identified in 9/64996 of European chromosomes by the Exome Aggregation Cons ortium (ExAC, http://exac.broadinstitute.org). |
Gene |
RCV000214569 | SCV000515520 | likely benign | not specified | 2016-12-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002054948 | SCV002393980 | likely benign | Myofibrillar myopathy 4 | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000214569 | SCV003928320 | benign | not specified | 2023-04-26 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000214569 | SCV001920626 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001726050 | SCV001963390 | likely benign | not provided | no assertion criteria provided | clinical testing |